Cargando…
The neuroprotective role of citicoline treatment in glaucoma – 6 months results of a prospective therapeutic trial
Objectives. Neuroprotective treatment, including citicoline, is a new perspective in glaucoma management, having the role of progression delay. The purpose of the present study was to observe the evolution of the different parameters in patients with glaucoma treated with citicoline. Methods. 22 pat...
Autores principales: | Chițu, Iulia, Voinea, Liliana-Mary, Istrate, Sânziana, Vrapciu, Alexandra, Ciuluvică, Radu Constantin, Tudosescu, Ruxandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Romanian Society of Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820495/ https://www.ncbi.nlm.nih.gov/pubmed/31687623 |
Ejemplares similares
-
Correlations between internal and external ocular
factors and macular pigment optical density
por: Tudosescu, Ruxandra, et al.
Publicado: (2018) -
Citicoline – a neuroprotector with proven
effects on glaucomatous disease
por: Iulia, Chitu, et al.
Publicado: (2017) -
Macular pigment density changes in central
serous chorioretinopathy
por: Tudosescu, Ruxandra, et al.
Publicado: (2018) -
Visual evoked potential in the early diagnosis of glaucoma.
Literature review
por: Firan, Anne Marie, et al.
Publicado: (2020) -
The role of Visual Evoked Potential (VEP) in monitoring the progression and in guiding the treatment of glaucoma patients with poor compliance
por: Firan, Anne Marie, et al.
Publicado: (2020)